Animal Cell Empirical Research Support Center

Location

48-27, Saneopdanji 1-gil, Pungsan-eup, Andong-si, Gyeongsangbuk-do, Republic of Korea (within the Gyeongbuk Bio Industrial Complex)

Function

Supporting the development and production of vaccines manufactured using animal cells and viruses

Scale

Site 45,621㎡, Building 16,120㎡(2 floors above ground, 3 buildings)

Completion

July 8, 2020 (Approved for use)

Facilities

Facilities		Composition and purpose	Service
GMP production facility	200L	200L adherent cell culture and purification system	Development and mass production of non-clinical and clinical concentrates
	200L	50L, 200L suspension cell culture and purification system
	1,000L	50L, 200L, 1,000L suspension cell culture and purification system
	BSL-3 (200L)	50L, 200L suspension cell culture and purification system	Cultivation of BSL-3 highly pathogenic viruses, Development and mass production of non-clinical and clinical concentrates
	Finished product (vial)	Vial filling system (12,000 vials/hr) (including freeze-drying)	Development and mass production of clinical and non-clinical finished products
	Finished product (syringe)	Prefilled syringe filling system (12,000 syringes/hr)
Process development facility		50L pilot scale	Development and optimization of vaccine production processes, production of non-clinical samples

Microbe Empirical Research Support Center

Location

132, Sandan-gil, Hwasun-eup, Hwasun-gun, Jeollanam-do, Republic of Korea (within the Biopharmaceutical industrial complex)

Function

Supporting the development and production of vaccines manufactured using microbes such as bacteria, E. coli, and yeast

Scale

Site 48,823㎡, Building 11,305㎡(3 floors above ground, 1 complex building)

Completion

April 3, 2020 (Approved for use)

Facilities

Facilities		Composition and purpose	Service
GMP production facility	50L	50L fermenters and purification systems	Production of clinical and non-clinical samples
	200L	50L, 200L fermenters and purification systems
	1,000L	50L (x1 unit), 500L (x2 units) fermenters and purification systems
	BSL-3 (200L)	50L, 200L fermenter	BSL-3 strain culture
	Finished product (vial)	5,000 vials/hr (including freeze-drying)	Filling of finished vial products
Process development facility		50L pilot scale	Development and optimization of vaccine production processes, production of non-clinical samples

Korea Bio
pharmaceutical
CMO Center

Public CMO for
Microbial-based
Vaccine